Darifenacin 16571-0767
Product NDC
16571-0767- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 19, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA206743
Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Darifenacin Hydrobromide | 7.5 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Packaging Options(2)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16571-767-03)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16571-767-09)